| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.17▼ | 1.17▼ | 1.17▼ | 1.20▼ | 1.21▼ |
| MA10 | 1.17▼ | 1.19▼ | 1.21▼ | 1.18▼ | 1.20▼ |
| MA20 | 1.19▼ | 1.23▼ | 1.22▼ | 1.22▼ | 1.31▼ |
| MA50 | 1.21▼ | 1.23▼ | 1.24▼ | 1.23▼ | 1.36▼ |
| MA100 | 1.25▼ | 1.29▼ | 1.27▼ | 1.33▼ | 1.60▼ |
| MA200 | 1.27▼ | 1.30▼ | 1.32▼ | 1.44▼ | 2.60▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.010▼ | -0.008▼ | -0.002▼ | -0.015▼ |
| RSI | 39.995▼ | 39.099▼ | 39.777▼ | 42.466▼ | 43.220▼ |
| STOCH | 37.554 | 6.946▼ | 3.341▼ | 48.296 | 29.828 |
| WILL %R | -81.818▼ | -93.750▼ | -93.750▼ | -82.759▼ | -85.075▼ |
| CCI | -97.436 | -87.566 | -110.717▼ | -71.795 | -52.922 |
|
Tuesday, September 22, 2026 06:07 AM
Merck enters Monday with pharmaceutical pipeline execution during a healthcare-heavy week. Healthcare Stocks remains shaped by rates, energy moves and changing demand. Verified market context points ...
|
|
Tuesday, September 22, 2026 05:14 AM
Merck (NYSE:MRK) received Japanese approval for KEYTRUDA QLEX (KEYJECT), its first subcutaneous KEYTRUDA formulation, for all existing local indications. The new subcutaneous version offers an ...
|
|
Tuesday, September 22, 2026 12:57 AM
Merck received FDA approval for a WINREVAIR label update based on Phase 3 HYPERION data showing reduced PAH clinical worsening events.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/26 | 1.22 | 1.22 | 1.15 | 1.15 | 29,519 |
| 24/09/26 | 1.2599 | 1.31 | 1.15 | 1.19 | 141,640 |
| 23/09/26 | 1.24 | 1.27 | 1.23 | 1.24 | 64,906 |
| 22/09/26 | 1.18 | 1.235 | 1.18 | 1.22 | 38,706 |
| 21/09/26 | 1.18 | 1.22 | 1.18 | 1.20 | 24,232 |
| 18/09/26 | 1.19 | 1.23 | 1.17 | 1.18 | 47,300 |
| 17/09/26 | 1.13 | 1.225 | 1.13 | 1.18 | 60,596 |
| 16/09/26 | 1.17 | 1.18 | 1.13 | 1.14 | 35,900 |
| 15/09/26 | 1.17 | 1.23 | 1.15 | 1.17 | 11,899 |
| 14/09/26 | 1.16 | 1.2302 | 1.16 | 1.17 | 17,380 |
|
|
||||
|
|
||||
|
|